- Veeva reported $928 million in fiscal Q2 FY27 revenue and $416 million in non-GAAP operating income, exceeding guidance and prompting a full-year outlook increase.
- Commercial subscription revenue rose approximately 13% year over year, with broad-based growth across CRM, content, data products, Crossix and Ostro.
- Vault CRM selections from Eli Lilly, Biogen and Regeneron supported a record CRM quarter, while Veeva expects potential Salesforce customer win-backs in 2027 and 2028.
- Falcon AI drew strong customer interest around efficiency, compliance and cost savings, with first go-lives expected this year as Veeva prepares the product for early adopters.
Quotes
“We want to be your plan B”
“exceptional”
“agentic labor”